CENTENNIAL, Colo.--(BUSINESS WIRE)--Inhibiton Therapeutics, Inc. (OTCBB: IHBT) announced today that it has signed an Agreement in Principle to acquire HPI Partners, LLC (“HPIP”) and its operating subsidiary AlumiFuel Power, Inc. (“AlumiFuel”) of Philadelphia, Pennsylvania. HPIP, through AlumiFuel, is an alternative energy company that is working to commercialize a process for generating hydrogen gas and steam on-site and on-demand for multiple niche applications.
